SAN DIEGO, Jan. 23, 2014 /PRNewswire/ -- Formex, LLC ("Formex"), a leader in pharmaceutical formulation and clinical trial manufacturing, announced today its sponsorship of the 3rd Drug Formulation & Bioavailability Conference to be held in Boston, MA from January 27-29, 2014.
Formex CSO Blair West, Ph.D. will be joined by distinguished speakers from Merck & Co, F Hoffman-La Roche, Novartis and Boehringer-Ingelheim for a discussion entitled "Accelerating Time to Market Through Innovation in Formulation Design and Drug Delivery."
Formex, a leading contract development and manufacturing organization (CDMO) maintains strong industry leadership in formulation design and drug delivery expertise especially within bioavailability enhancement. Formex offerings include Hot Melt Extrusion, Spray Dried Dispersions and other formulation design technologies and cGMP manufacturing on a fee for service contract basis.
About Formex, LLC
Formex, LLC is a leading CDMO based in San Diego, CA. Formex specializes in bioavailability enhancement and controlled release technologies, such as hot melt extrusion, spray drying, fluid bed processing, and liquid/semi-solid filled hard capsules as well as cGMP manufacturing for development and beyond.
SOURCE Formex, LLC